Send feedback

DYSF p.Asp320fs

c.959dup · rs1559057405 · VCV2674961

Pathogenic Expert panel
Classification
Pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 5 submitters
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 0.000339%, nfe)
Conditions
5
autosomal recessive limb-girdle muscular dystrophy

ClinGen expert panel — Limb Girdle Muscular Dystrophy VCEP

Pathogenic for autosomal recessive limb-girdle muscular dystrophy. Applied ACMG criteria (verbatim):

PVS1 PM3_Supporting PM2_Supporting

Curation rationale (ClinGen, verbatim)

The NM_003494.4: c.863dup p.(Asp288GlufsTer40) variant in DYSF, which is also known as NM_001130987.2: c.959dup p.(Asp320GlufsTer40), is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 11/55, leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant has been identified in at least two individuals with dysferlinopathy (PMID: 36983702, 33715265, 14673575; LOVD DYSF_000186), including in unknown phase with a pathogenic variant (NM_003494.4: c.3031+2T>C, 0.5 pts, PMID: 36983702; PM3_Supporting). The filtering allele frequency of this variant in gnomAD v4.1.0 exomes is 0.000008232 (the upper threshold of the 95% CI of 4/1111996 European (non-Finnish) chromosomes), which is lower than the ClinGen LGMD VCEP threshold (<0.0001) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb-girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 07/29/2025): PVS1, PM3_Supporting, PM2_Supporting.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function
NMDpredictedpremature termination codon in exon 10 of 56
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP 9.8GERP 1.9, phastCons 1

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000339% European (non-Finnish) · 4/1,180,028 alleles
Filtering AF 7.9e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 5.4e-05%
Overall 0.000274% 4/1,461,864 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DYSF
Protein
p.Asp320fs
Coding
c.959dup
MANE Select
NM_001130987
dbSNP
rs1559057405
Type
Duplication
Location
chr2:71516995 (GRCh38)
Gene constraint
LOEUF 0.836 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 79.25 · 11 PDB
Residue 320
a β-strand; the c2 2 domain
Full DYSF gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dysf-p-asp320fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown